TERN-101
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for TERN-101, covering 2022-06-14 to 2025-03-12. Get the full timeline:
Most recent: Clinical Trial Update: DUET Study: A Clinical Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Orally Administered TERN-501 as Monotherapy and in Combination With TERN-101 in Noncirrhotic Adults With Presumed Non-Alcoholic Steatohepatitis [Phase 2]